Loading…
Healthcare utilization and costs among patients with non-functioning pituitary adenomas
Purpose Non-functioning pituitary adenomas (NFPA) have a substantial impact on patients’ health status, yet research on the extent of healthcare utilization and costs among these patients is scarce. The objective was to determine healthcare usage, associated costs, and their determinants among patie...
Saved in:
| Published in: | Endocrine 2019-05, Vol.64 (2), p.330-340 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3 |
| container_end_page | 340 |
| container_issue | 2 |
| container_start_page | 330 |
| container_title | Endocrine |
| container_volume | 64 |
| creator | Lobatto, Daniel J. van den Hout, Wilbert B. Zamanipoor Najafabadi, Amir H. Steffens, Anath N. V. Andela, Cornelie D. Pereira, Alberto M. Peul, Wilco C. van Furth, Wouter R. Biermasz, Nienke R. Vliet Vlieland, Thea P. M. |
| description | Purpose
Non-functioning pituitary adenomas (NFPA) have a substantial impact on patients’ health status, yet research on the extent of healthcare utilization and costs among these patients is scarce. The objective was to determine healthcare usage, associated costs, and their determinants among patients treated for an NFPA.
Methods
In a cross-sectional study, 167 patients treated for an NFPA completed four validated questionnaires. Annual healthcare utilization and associated costs were assessed through the medical consumption questionnaire (MTA iMCQ). In addition, the Leiden Bother and Needs Questionnaire for pituitary patients (LBNQ-Pituitary), Short Form-36 (SF-36), and EuroQol (EQ-5D) were administered. Furthermore, age, sex, endocrine status, treatment, and duration of follow-up were extracted from the medical records. Associations were analyzed using logistic/linear regression.
Results
Annual healthcare utilization included: consultation of an endocrinologist (95% of patients), neurosurgeon (14%), and/or ophthalmologist (58%). Fourteen percent of patients had ≥1 hospitalization(s) and 11% ≥1 emergency room visit(s). Mean overall annual healthcare costs were € 3040 (SD 6498), highest expenditures included medication (31%), inpatient care (28%), and specialist care (17%). Factors associated with higher healthcare utilization and costs were greater self-perceived disease bother and need for support, worse mental and physical health status, younger age, and living alone.
Conclusion
Healthcare usage and costs among patients treated for an NFPA are substantial and were associated with self-perceived health status, disease bother, and healthcare needs rather than endocrine status, treatment, or duration of follow-up. These findings suggest that targeted interventions addressing disease bother and unmet needs in the chronic phase are needed. |
| doi_str_mv | 10.1007/s12020-019-01847-7 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6531397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2196528852</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3</originalsourceid><addsrcrecordid>eNp9UU1v1DAUtBAVLYU_wAFF4sIl8PwVJxckVAFFqsSlVblZb21n11ViL7ZTBL8ehy3l48DBen5-4_GMh5BnFF5RAPU6UwYMWqBDXb1QrXpATqiUawvwsO65lC1A__mYPM75BoAx1qlH5JjDAFwqOCHX5w6nsjOYXLMUP_nvWHwMDQbbmJhLbnCOYdvs67ELtf3qy64JMbTjEswK9evUl8UXTN8atC7EGfMTcjTilN3Tu3pKrt6_uzw7by8-ffh49vaiNUKJ0o7UDZYi58ZyUIPoLG6AVzcdMuHAMDZauhGSWcFGplQPqKzoaqUU3cbwU_LmwLtfNrOzpmpMOOl98nOVoyN6_fck-J3exlvdSU75oCrByzuCFL8sLhc9-2zcNGFwccma0aGTrO8lq9AX_0Bv4pJCtafrxw5MUkF5RbEDyqSYc3LjvRgKes1NH3LTNTf9Mze9qnj-p437K7-CqgB-AOQ6CluXfr_9H9ofFl6k4w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229251413</pqid></control><display><type>article</type><title>Healthcare utilization and costs among patients with non-functioning pituitary adenomas</title><source>Springer Link</source><creator>Lobatto, Daniel J. ; van den Hout, Wilbert B. ; Zamanipoor Najafabadi, Amir H. ; Steffens, Anath N. V. ; Andela, Cornelie D. ; Pereira, Alberto M. ; Peul, Wilco C. ; van Furth, Wouter R. ; Biermasz, Nienke R. ; Vliet Vlieland, Thea P. M.</creator><creatorcontrib>Lobatto, Daniel J. ; van den Hout, Wilbert B. ; Zamanipoor Najafabadi, Amir H. ; Steffens, Anath N. V. ; Andela, Cornelie D. ; Pereira, Alberto M. ; Peul, Wilco C. ; van Furth, Wouter R. ; Biermasz, Nienke R. ; Vliet Vlieland, Thea P. M.</creatorcontrib><description>Purpose
Non-functioning pituitary adenomas (NFPA) have a substantial impact on patients’ health status, yet research on the extent of healthcare utilization and costs among these patients is scarce. The objective was to determine healthcare usage, associated costs, and their determinants among patients treated for an NFPA.
Methods
In a cross-sectional study, 167 patients treated for an NFPA completed four validated questionnaires. Annual healthcare utilization and associated costs were assessed through the medical consumption questionnaire (MTA iMCQ). In addition, the Leiden Bother and Needs Questionnaire for pituitary patients (LBNQ-Pituitary), Short Form-36 (SF-36), and EuroQol (EQ-5D) were administered. Furthermore, age, sex, endocrine status, treatment, and duration of follow-up were extracted from the medical records. Associations were analyzed using logistic/linear regression.
Results
Annual healthcare utilization included: consultation of an endocrinologist (95% of patients), neurosurgeon (14%), and/or ophthalmologist (58%). Fourteen percent of patients had ≥1 hospitalization(s) and 11% ≥1 emergency room visit(s). Mean overall annual healthcare costs were € 3040 (SD 6498), highest expenditures included medication (31%), inpatient care (28%), and specialist care (17%). Factors associated with higher healthcare utilization and costs were greater self-perceived disease bother and need for support, worse mental and physical health status, younger age, and living alone.
Conclusion
Healthcare usage and costs among patients treated for an NFPA are substantial and were associated with self-perceived health status, disease bother, and healthcare needs rather than endocrine status, treatment, or duration of follow-up. These findings suggest that targeted interventions addressing disease bother and unmet needs in the chronic phase are needed.</description><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-019-01847-7</identifier><identifier>PMID: 30903570</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adenoma - economics ; Aged ; Cross-Sectional Studies ; Diabetes ; Emergency medical care ; Endocrinology ; Female ; Health Expenditures ; Health Status ; Humanities and Social Sciences ; Humans ; Internal Medicine ; Male ; Medical records ; Medicine ; Medicine & Public Health ; Middle Aged ; multidisciplinary ; Original ; Original Article ; Patient Acceptance of Health Care ; Patients ; Pituitary ; Pituitary Neoplasms - economics ; Questionnaires ; Science ; Surveys and Questionnaires ; Tumors</subject><ispartof>Endocrine, 2019-05, Vol.64 (2), p.330-340</ispartof><rights>The Author(s) 2019</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3</citedby><cites>FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3</cites><orcidid>0000-0002-2523-8707</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30903570$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lobatto, Daniel J.</creatorcontrib><creatorcontrib>van den Hout, Wilbert B.</creatorcontrib><creatorcontrib>Zamanipoor Najafabadi, Amir H.</creatorcontrib><creatorcontrib>Steffens, Anath N. V.</creatorcontrib><creatorcontrib>Andela, Cornelie D.</creatorcontrib><creatorcontrib>Pereira, Alberto M.</creatorcontrib><creatorcontrib>Peul, Wilco C.</creatorcontrib><creatorcontrib>van Furth, Wouter R.</creatorcontrib><creatorcontrib>Biermasz, Nienke R.</creatorcontrib><creatorcontrib>Vliet Vlieland, Thea P. M.</creatorcontrib><title>Healthcare utilization and costs among patients with non-functioning pituitary adenomas</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>Purpose
Non-functioning pituitary adenomas (NFPA) have a substantial impact on patients’ health status, yet research on the extent of healthcare utilization and costs among these patients is scarce. The objective was to determine healthcare usage, associated costs, and their determinants among patients treated for an NFPA.
Methods
In a cross-sectional study, 167 patients treated for an NFPA completed four validated questionnaires. Annual healthcare utilization and associated costs were assessed through the medical consumption questionnaire (MTA iMCQ). In addition, the Leiden Bother and Needs Questionnaire for pituitary patients (LBNQ-Pituitary), Short Form-36 (SF-36), and EuroQol (EQ-5D) were administered. Furthermore, age, sex, endocrine status, treatment, and duration of follow-up were extracted from the medical records. Associations were analyzed using logistic/linear regression.
Results
Annual healthcare utilization included: consultation of an endocrinologist (95% of patients), neurosurgeon (14%), and/or ophthalmologist (58%). Fourteen percent of patients had ≥1 hospitalization(s) and 11% ≥1 emergency room visit(s). Mean overall annual healthcare costs were € 3040 (SD 6498), highest expenditures included medication (31%), inpatient care (28%), and specialist care (17%). Factors associated with higher healthcare utilization and costs were greater self-perceived disease bother and need for support, worse mental and physical health status, younger age, and living alone.
Conclusion
Healthcare usage and costs among patients treated for an NFPA are substantial and were associated with self-perceived health status, disease bother, and healthcare needs rather than endocrine status, treatment, or duration of follow-up. These findings suggest that targeted interventions addressing disease bother and unmet needs in the chronic phase are needed.</description><subject>Adenoma - economics</subject><subject>Aged</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Emergency medical care</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Health Expenditures</subject><subject>Health Status</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical records</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>multidisciplinary</subject><subject>Original</subject><subject>Original Article</subject><subject>Patient Acceptance of Health Care</subject><subject>Patients</subject><subject>Pituitary</subject><subject>Pituitary Neoplasms - economics</subject><subject>Questionnaires</subject><subject>Science</subject><subject>Surveys and Questionnaires</subject><subject>Tumors</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v1DAUtBAVLYU_wAFF4sIl8PwVJxckVAFFqsSlVblZb21n11ViL7ZTBL8ehy3l48DBen5-4_GMh5BnFF5RAPU6UwYMWqBDXb1QrXpATqiUawvwsO65lC1A__mYPM75BoAx1qlH5JjDAFwqOCHX5w6nsjOYXLMUP_nvWHwMDQbbmJhLbnCOYdvs67ELtf3qy64JMbTjEswK9evUl8UXTN8atC7EGfMTcjTilN3Tu3pKrt6_uzw7by8-ffh49vaiNUKJ0o7UDZYi58ZyUIPoLG6AVzcdMuHAMDZauhGSWcFGplQPqKzoaqUU3cbwU_LmwLtfNrOzpmpMOOl98nOVoyN6_fck-J3exlvdSU75oCrByzuCFL8sLhc9-2zcNGFwccma0aGTrO8lq9AX_0Bv4pJCtafrxw5MUkF5RbEDyqSYc3LjvRgKes1NH3LTNTf9Mze9qnj-p437K7-CqgB-AOQ6CluXfr_9H9ofFl6k4w</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Lobatto, Daniel J.</creator><creator>van den Hout, Wilbert B.</creator><creator>Zamanipoor Najafabadi, Amir H.</creator><creator>Steffens, Anath N. V.</creator><creator>Andela, Cornelie D.</creator><creator>Pereira, Alberto M.</creator><creator>Peul, Wilco C.</creator><creator>van Furth, Wouter R.</creator><creator>Biermasz, Nienke R.</creator><creator>Vliet Vlieland, Thea P. M.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2523-8707</orcidid></search><sort><creationdate>20190501</creationdate><title>Healthcare utilization and costs among patients with non-functioning pituitary adenomas</title><author>Lobatto, Daniel J. ; van den Hout, Wilbert B. ; Zamanipoor Najafabadi, Amir H. ; Steffens, Anath N. V. ; Andela, Cornelie D. ; Pereira, Alberto M. ; Peul, Wilco C. ; van Furth, Wouter R. ; Biermasz, Nienke R. ; Vliet Vlieland, Thea P. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenoma - economics</topic><topic>Aged</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Emergency medical care</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Health Expenditures</topic><topic>Health Status</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical records</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>multidisciplinary</topic><topic>Original</topic><topic>Original Article</topic><topic>Patient Acceptance of Health Care</topic><topic>Patients</topic><topic>Pituitary</topic><topic>Pituitary Neoplasms - economics</topic><topic>Questionnaires</topic><topic>Science</topic><topic>Surveys and Questionnaires</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lobatto, Daniel J.</creatorcontrib><creatorcontrib>van den Hout, Wilbert B.</creatorcontrib><creatorcontrib>Zamanipoor Najafabadi, Amir H.</creatorcontrib><creatorcontrib>Steffens, Anath N. V.</creatorcontrib><creatorcontrib>Andela, Cornelie D.</creatorcontrib><creatorcontrib>Pereira, Alberto M.</creatorcontrib><creatorcontrib>Peul, Wilco C.</creatorcontrib><creatorcontrib>van Furth, Wouter R.</creatorcontrib><creatorcontrib>Biermasz, Nienke R.</creatorcontrib><creatorcontrib>Vliet Vlieland, Thea P. M.</creatorcontrib><collection>Springer Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lobatto, Daniel J.</au><au>van den Hout, Wilbert B.</au><au>Zamanipoor Najafabadi, Amir H.</au><au>Steffens, Anath N. V.</au><au>Andela, Cornelie D.</au><au>Pereira, Alberto M.</au><au>Peul, Wilco C.</au><au>van Furth, Wouter R.</au><au>Biermasz, Nienke R.</au><au>Vliet Vlieland, Thea P. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Healthcare utilization and costs among patients with non-functioning pituitary adenomas</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>64</volume><issue>2</issue><spage>330</spage><epage>340</epage><pages>330-340</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Purpose
Non-functioning pituitary adenomas (NFPA) have a substantial impact on patients’ health status, yet research on the extent of healthcare utilization and costs among these patients is scarce. The objective was to determine healthcare usage, associated costs, and their determinants among patients treated for an NFPA.
Methods
In a cross-sectional study, 167 patients treated for an NFPA completed four validated questionnaires. Annual healthcare utilization and associated costs were assessed through the medical consumption questionnaire (MTA iMCQ). In addition, the Leiden Bother and Needs Questionnaire for pituitary patients (LBNQ-Pituitary), Short Form-36 (SF-36), and EuroQol (EQ-5D) were administered. Furthermore, age, sex, endocrine status, treatment, and duration of follow-up were extracted from the medical records. Associations were analyzed using logistic/linear regression.
Results
Annual healthcare utilization included: consultation of an endocrinologist (95% of patients), neurosurgeon (14%), and/or ophthalmologist (58%). Fourteen percent of patients had ≥1 hospitalization(s) and 11% ≥1 emergency room visit(s). Mean overall annual healthcare costs were € 3040 (SD 6498), highest expenditures included medication (31%), inpatient care (28%), and specialist care (17%). Factors associated with higher healthcare utilization and costs were greater self-perceived disease bother and need for support, worse mental and physical health status, younger age, and living alone.
Conclusion
Healthcare usage and costs among patients treated for an NFPA are substantial and were associated with self-perceived health status, disease bother, and healthcare needs rather than endocrine status, treatment, or duration of follow-up. These findings suggest that targeted interventions addressing disease bother and unmet needs in the chronic phase are needed.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30903570</pmid><doi>10.1007/s12020-019-01847-7</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-2523-8707</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1355-008X |
| ispartof | Endocrine, 2019-05, Vol.64 (2), p.330-340 |
| issn | 1355-008X 1559-0100 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6531397 |
| source | Springer Link |
| subjects | Adenoma - economics Aged Cross-Sectional Studies Diabetes Emergency medical care Endocrinology Female Health Expenditures Health Status Humanities and Social Sciences Humans Internal Medicine Male Medical records Medicine Medicine & Public Health Middle Aged multidisciplinary Original Original Article Patient Acceptance of Health Care Patients Pituitary Pituitary Neoplasms - economics Questionnaires Science Surveys and Questionnaires Tumors |
| title | Healthcare utilization and costs among patients with non-functioning pituitary adenomas |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T23%3A35%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Healthcare%20utilization%20and%20costs%20among%20patients%20with%20non-functioning%20pituitary%20adenomas&rft.jtitle=Endocrine&rft.au=Lobatto,%20Daniel%20J.&rft.date=2019-05-01&rft.volume=64&rft.issue=2&rft.spage=330&rft.epage=340&rft.pages=330-340&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-019-01847-7&rft_dat=%3Cproquest_pubme%3E2196528852%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-f1e9d1a33cd307946dab030186a24e0c22fd1b452d42f27780a7d4678011aebc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229251413&rft_id=info:pmid/30903570&rfr_iscdi=true |